Literature DB >> 17493712

Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Robert P Wise1, Jan Bonhoeffer, Judy Beeler, Hugo Donato, Peter Downie, Dana Matthews, Vitali Pool, Marianne Riise-Bergsaker, Terhi Tapiainen, Frederick Varricchio.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17493712     DOI： 10.1016/j.vaccine.2007.02.067

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  12 in total

1.  Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.

Authors:  Lakshmi Sukumaran; Michael M McNeil; Pedro L Moro; Paige W Lewis; Scott K Winiecki; Tom T Shimabukuro
Journal:  Clin Infect Dis       Date:  2015-01-30       Impact factor: 9.079

2.  Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.

Authors:  Silvia Perez-Vilar; Graça M Dores; Paige L Marquez; Carmen S Ng; Maria V Cano; Anuja Rastogi; Lucia Lee; John R Su; Jonathan Duffy
Journal:  Vaccine       Date:  2021-12-07       Impact factor: 3.641

3.  Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports.

Authors:  Wenxin Guo; Jessica Deguise; Yujia Tian; Philip Chi-En Huang; Rohit Goru; Qiuyue Yang; Suyuan Peng; Luxia Zhang; Lili Zhao; Jiangan Xie; Yongqun He
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

4.  Template protocol for clinical trials investigating vaccines--focus on safety elements.

Authors:  Jan Bonhoeffer; Egeruan B Imoukhuede; Grace Aldrovandi; Novilia S Bachtiar; Eng-Soon Chan; Soju Chang; Robert T Chen; Rohini Fernandopulle; Karen L Goldenthal; James D Heffelfinger; Shah Hossain; Indira Jevaji; Ali Khamesipour; Sonali Kochhar; Mamodikoe Makhene; Elissa Malkin; David Nalin; Rebecca Prevots; Ranjan Ramasamy; Sarah Sellers; Johan Vekemans; Kenneth B Walker; Pam Wilson; Virginia Wong; Khalequz Zaman; Ulrich Heininger
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

5.  Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Authors:  Mark D Gershman; J Erin Staples; Adwoa D Bentsi-Enchill; J Gabrielle Breugelmans; Glacus S Brito; Luiz Antonio Bastos Camacho; Pascale Cottin; Cristina Domingo; Anna Durbin; Joaquim Gascon; Fouzia Guenaneche; Edward B Hayes; Zsuzsanna Jelenik; Alena Khromava; Reinaldo de Menezes Martins; Mario Masana Wilson; Nathalie Massy; Abdulsalami Nasidi; Matthias Niedrig; Adam Sherwat; Theodore Tsai; Anna Vilella; Mary Elizabeth Wilson; Katrin S Kohl
Journal:  Vaccine       Date:  2012-05-04       Impact factor: 3.641

6.  Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012.

Authors:  B J Law; J Laflèche; N Ahmadipour; H Anyoti
Journal:  Can Commun Dis Rep       Date:  2014-12-04

7.  Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

Authors:  Silvia Perez-Vilar; Daniel Weibel; Miriam Sturkenboom; Steven Black; Christine Maure; Jose Luis Castro; Pamela Bravo-Alcántara; Caitlin N Dodd; Silvana A Romio; Maria de Ridder; Swabra Nakato; Helvert Felipe Molina-León; Varalakshmi Elango; Patrick L F Zuber
Journal:  Vaccine       Date:  2017-05-27       Impact factor: 3.641

8.  Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.

Authors:  Fan-Ya Meng; Yong Sun; Yong-Gang Shen; Hai-Feng Pan; Ji-Hai Tang; Bin-Bing Wang; Chang-Hao Wu; Dong-Qing Ye
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

9.  Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy.

Authors:  Marco Villa; Steven Black; Nicola Groth; Kenneth J Rothman; Giovanni Apolone; Noel S Weiss; Ivana Aquino; Liana Boldori; Fausta Caramaschi; Antonio Gattinoni; Giancarlo Malchiodi; Antonio Crucitti; Giovanni Della Cioppa; Elio Scarpini; Domenico Mavilio; Salvatore Mannino
Journal:  Am J Epidemiol       Date:  2013-07-17       Impact factor: 4.897

10.  Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.

Authors:  Rosalind Rowland; Geraldine A O'Hara; Matthew Hamill; Ian D Poulton; Hannah Donaldson; Laura Dinsmore; Timothy James; Eleanor Barnes; Paul Klenerman; Sarah C Gilbert; Adrian V S Hill; Brian Shine; Helen McShane
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.